ANTI-PARKINSON DRUGS IN PARANOID SCHIZOPHRENIA

被引：0
|
作者：
CAVENAR, JO
BRAASCH, ER
SULLIVAN, JL
机构：
来源：
NORTH CAROLINA MEDICAL JOURNAL | 1979年 / 40卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：287 / 288
页数：2
相关论文
共 50 条
  • [1] REVERSAL OF SOME THERAPEUTIC EFFECTS OF HALOPERIDOL IN SCHIZOPHRENIA BY ANTI-PARKINSON DRUGS
    SINGH, M
    SMITH, JM
    PHARMACOLOGIST, 1971, 13 (02): : 207 - &
  • [2] ANTI-PARKINSON DRUGS AND OREXIN NEURONS
    Katsuki, Hiroshi
    Michinaga, Shotaro
    VITAMINS AND HORMONES: SLEEP HORMONES, VOL 89, 2012, 89 : 279 - 290
  • [3] Isostructural metabolites of two anti-Parkinson drugs
    Simon, K
    Harmat, V
    Torok, Z
    Bocskei, Z
    Hermecz, I
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 1998, 54 : 811 - 813
  • [4] The evolution of use of anti-Parkinson drugs in Spain
    Montané, E
    Vallano, A
    Castel, JM
    REVISTA DE NEUROLOGIA, 2002, 34 (07) : 612 - 617
  • [5] ABUSE OF THE ANTI-PARKINSON DRUGS - A REVIEW OF THE LITERATURE
    SMITH, JM
    JOURNAL OF CLINICAL PSYCHIATRY, 1980, 41 (10) : 351 - 354
  • [6] EFFECTS OF ANTI-PARKINSON DRUGS ON CORTICAL NEURONS
    CLARKE, G
    DAVIES, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1973, 47 (03) : 465 - 475
  • [7] METABOLISM OF ANTI-PARKINSON DRUGS - EXAMPLE OF COMPETITIVE HYDROXYLATION
    STOCK, B
    SPITELLER, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1979, 29-1 (04): : 610 - 615
  • [8] Fracture Risk Associated with Parkinsonism and Anti-Parkinson Drugs
    Peter Vestergaard
    Lars Rejnmark
    Leif Mosekilde
    Calcified Tissue International, 2007, 81 : 153 - 161
  • [9] POTENTIAL ANTI-PARKINSON DRUGS DESIGNED BY RECEPTOR MAPPING
    MARTIN, YC
    JARBOE, CH
    KRAUSE, RA
    LYNN, KR
    DUNNIGAN, D
    HOLLAND, JB
    JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (02) : 147 - 150
  • [10] Sleep attacks induced by anti-Parkinson disease drugs
    Miranda, M
    Díaz, V
    Venegas, P
    Villagra, R
    REVISTA MEDICA DE CHILE, 2001, 129 (05) : 585 - 586
12345